Elevation of CA 19-9 in Benign Non-pancreaticobiliary Diseases

Introduction: Although CA 19-9, as a tumor marker, may be elevated in benign diseases, elevated CA 19-9 may lead a fear of cancer and unnecessary follow-up studies. Aims: The aim of this study was to analyze the clinical features of elevated CA 19-9 in benign diseases Materials & methods:

Saved in:
Bibliographic Details
Published in:Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2017-07, Vol.17 (3), p.S114-S114
Main Authors: Park, Byung Kyu, Seo, Jeong Hoon, Park, Yongjung, Han, Joung-Ho
Format: Article
Language:English
Subjects:
Benign
Cancer
Disease
Endocrinology & Metabolism
Gastroenterology and Hepatology
Tumor markers
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Although CA 19-9, as a tumor marker, may be elevated in benign diseases, elevated CA 19-9 may lead a fear of cancer and unnecessary follow-up studies. Aims: The aim of this study was to analyze the clinical features of elevated CA 19-9 in benign diseases Materials & methods:
ISSN:1424-3903
1424-3911
DOI:10.1016/j.pan.2017.05.358